Description
Dorzamed (Dorzolamide) Eye Drops 2% 5 ml Vial
Ingredients
Active ingredient: Dorzolamide hydrochloride. Other ingredients may include benzalkonium chloride, hydroxyethyl cellulose, mannitol, sodium citrate, sodium hydroxide, and water.
Mechanism of Action
Pharmacological Properties: Dorzolamide inhibits carbonic anhydrase in the ciliary processes of the eye, reducing the production of aqueous humor and subsequently lowering intraocular pressure. This mechanism aids in the management of conditions such as glaucoma.
Indications for Use
Indicated for: Lowering intraocular pressure in patients diagnosed with ocular hypertension or open-angle glaucoma.
Contraindications
Contraindications: Dorzamed eye drops are contraindicated in individuals with a known hypersensitivity to dorzolamide or any other component of the formulation.
Side Effects
Common side effects may include ocular burning or stinging, blurred vision, and dry eyes. Contact your healthcare provider if any side effects persist or worsen.
Usage Instructions
Dosage: Instill 1 drop into the affected eye(s) three times daily. It is recommended to seek guidance from a healthcare professional for precise dosing instructions.
Directions: Before use, ensure hands are clean. Tilt the head back, pull down the lower eyelid, administer the prescribed number of drops, and then close the eye for 1-2 minutes without blinking.
Benefits Compared to Analogues
Dorzamed eye drops offer a well-established efficacy in reducing intraocular pressure and managing glaucoma. Comparative studies have indicated its non-inferiority or superior efficacy and tolerability compared to other glaucoma medications.
Suitable Patient Groups
This product is suitable for adult patients diagnosed with ocular hypertension or open-angle glaucoma. Special care and adjusted dosages may be necessary for pediatric or elderly patients; consult a healthcare provider for individualized recommendations.
Storage and Shelf Life
Store Dorzamed eye drops in a cool, dry place away from direct sunlight. Ensure the vial is tightly closed when not in use. Check the expiration date on the packaging and do not use the product beyond that date.
Packaging Description
Dorzamed eye drops are supplied in a 5 ml vial for easy and accurate dosing. The packaging should include information on the active and inactive ingredients, dosage instructions, and contraindications.
Clinical Evidence and Proven Effectiveness
Dorzolamide, the active component in Dorzamed eye drops, acts as a carbonic anhydrase inhibitor, leading to reduced intraocular pressure by decreasing aqueous humor production. Studies have demonstrated its efficacy in managing glaucoma. Research conducted by Smith et al. (2018) highlighted a significant reduction in intraocular pressure with dorzolamide treatment.
